Merck (MRK) FCF Payout Ratio Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Cover Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-94.03% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
141.61% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-58.56% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-58.88% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-29.55% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-29.45% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-18.46% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
128.23% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-58.88% |
| Dec 31, 2025 |
42.51% |
| Sep 30, 2025 |
29.45% |
| Jun 30, 2025 |
100.40% |
| Mar 31, 2025 |
99.94% |
| Dec 31, 2024 |
131.15% |
| Sep 30, 2024 |
-15.67% |
| Jun 30, 2024 |
-40.45% |
| Mar 31, 2024 |
-84.33% |
| Dec 31, 2023 |
-567.33% |
| Sep 30, 2023 |
-30.26% |
| Jun 30, 2023 |
23.37% |
| Mar 31, 2023 |
1,108.06% |
| Dec 31, 2022 |
26.19% |
| Sep 30, 2022 |
-14.20% |
| Jun 30, 2022 |
-66.52% |
| Mar 31, 2022 |
-95.56% |
| Dec 31, 2021 |
-45.75% |
| Sep 30, 2021 |
-62.31% |
| Jun 30, 2021 |
42.75% |
| Mar 31, 2021 |
287.28% |
| Dec 31, 2020 |
144.09% |
| Sep 30, 2020 |
182.88% |
| Jun 30, 2020 |
83.04% |
| Mar 31, 2020 |
-388.47% |
| Dec 31, 2019 |
-468.54% |
| Sep 30, 2019 |
-28.94% |
| Jun 30, 2019 |
36.15% |
| Mar 31, 2019 |
4.59% |
| Dec 31, 2018 |
23.49% |
| Sep 30, 2018 |
175.44% |
| Jun 30, 2018 |
4.79% |
| Mar 31, 2018 |
107.55% |
| Dec 31, 2017 |
-5.87% |
| Sep 30, 2017 |
-260.06% |
| Jun 30, 2017 |
-57.88% |
| Mar 31, 2017 |
-3,715.50% |
| Dec 31, 2016 |
22.58% |
| Sep 30, 2016 |
17.08% |
| Jun 30, 2016 |
97.74% |
| Mar 31, 2016 |
9.79% |
| Dec 31, 2015 |
140.76% |
| Sep 30, 2015 |
33.44% |
| Jun 30, 2015 |
-19.32% |
| Mar 31, 2015 |
2.80% |
| Dec 31, 2014 |
-270.16% |
| Sep 30, 2014 |
-9.14% |
| Jun 30, 2014 |
-3.87% |
| Mar 31, 2014 |
-8.83% |
| Dec 31, 2013 |
113.46% |
| Sep 30, 2013 |
-25.25% |
| Jun 30, 2013 |
34.55% |
| Mar 31, 2013 |
-6.46% |
| Dec 31, 2012 |
-178.31% |
| Sep 30, 2012 |
65.35% |
| Jun 30, 2012 |
8.76% |
| Mar 31, 2012 |
-16.59% |
| Dec 31, 2011 |
-8.39% |
| Sep 30, 2011 |
-45.91% |
| Jun 30, 2011 |
18.83% |
| Mar 31, 2011 |
-27.63% |
| Dec 31, 2010 |
-350.37% |
| Sep 30, 2010 |
140.11% |
| Jun 30, 2010 |
-80.99% |
| Mar 31, 2010 |
-30.93% |
